Logo image
Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial
Journal article   Peer reviewed

Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial

Colin P Derdeyn and Marc I Chimowitz
Neuroimaging clinics of North America, Vol.17(3), pp.355-363
08/2007
DOI: 10.1016/j.nic.2007.05.001
PMCID: PMC2040119
PMID: 17826637
url
http://doi.org/10.1016/j.nic.2007.05.001View
Open Access

Abstract

Atherosclerotic disease of the major intracranial arteries is a frequent cause of stroke. In addition, many patients who have symptomatic intracranial stenosis are at very high risk for recurrent stroke. Preliminary studies suggest that angioplasty and stenting may reduce the risk of stroke in patients who have severe stenosis of intracranial arteries. Data for angioplasty and stenting, however, consist of case series; no randomized studies have been completed to date. This article reviews these data and discusses the rationale for a randomized trial of angioplasty and stenting versus best medical management for patients who have symptomatic intracranial stenosis.
Carotid Arteries - drug effects Intracranial Arteriosclerosis - drug therapy Cerebral Arteries - surgery Constriction, Pathologic - therapy Humans Carotid Stenosis - drug therapy Carotid Stenosis - therapy Anticoagulants - therapeutic use Angioplasty - methods Randomized Controlled Trials as Topic Cerebral Arteries - drug effects Brain - blood supply Constriction, Pathologic - drug therapy Constriction, Pathologic - surgery Intracranial Arteriosclerosis - surgery Cerebral Arteries - pathology Carotid Arteries - surgery Carotid Arteries - pathology Intracranial Arteriosclerosis - therapy Stents Carotid Stenosis - surgery

Details

Metrics

Logo image